New delivery model applies AI across engineering, testing, DevOps, and analytics to improve speed, transparency, and ...
The new associate degree programs include Data Analytics, Digital Media Marketing and Communications, Health Sciences (with ...
Using commercially available technology and innovative methods, researchers at NBI have pushed the limits of how fast you can ...
The vast majority of agentic AI systems disclose nothing about what safety testing, if any, has been conducted, and many systems have no documented way to shut down a rogue bot, a study by MIT and ...
QUÉBEC — Christine Fréchette, leadership candidate for the Coalition Avenir Québec, is promising to revive a popular fast-track immigration program that her government had recently ended. She says if ...
Warp, which builds software to help developers control AI agents and other software from the command line, is rolling out a new tool called Oz to collaboratively command AI in the cloud. But, says ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Damian Garde is a reporter at ...
WASHINGTON (AP) — A Democratic lawmaker raised new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs, including whether senior officials ...
The U.S. Food and Drug Administration started taking applications for its PreCheck pilot, a new effort to accelerate the construction and review of pharmaceutical manufacturing facilities in the ...
French President Emmanuel Macron says he wants his government to fast-track the legal process to ensure that a ban on social media for children under the age of 15 can enter into force in September at ...
Pennsylvania College of Technology will offer a four-month Advanced Manufacturing Pre-Apprenticeship program through Allentown School District beginning Jan. 23, introducing students to foundational ...
WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and outside experts, with some saying the poorly defined effort ...